Private equity firm Montagu will retain the ownership of both companies, which will collaborate with medical technology companies to design and develop medical devices
RTI Surgical tissue processors follow strict inspection criteria to provide quality implants. (Credit: RTI Surgical)
Global private label OEM company RTI Surgical has announced spin off of its businesses into two independent companies to better meet the requirements of customers and patients in their specific market segments.
The company will split its metal business to operate independently under the name Resolve Surgical Technologies, while the tissue and biologics business will continue with the RTI Surgical name.
Private equity company Montagu will retain the ownership of both companies, which will collaborate with medical technology companies to design and develop medical devices.
The tissues and biologics business offers a range of tissue-based surgical implants across multiple market segments and commercial channels.
RTI Surgical CEO Olivier Visa will continue to manage the business, which is based in Alachua, Florida.
The company operates manufacturing facilities in Greenville of North Carolina and Neunkirchen of Germany. It is said to be the first company to provide precision-tooled bone implants and assembled technology to maximise each gift of tissue donation.
In a statement, Visa said: “Our team is passionate about partnering with our customers to develop and deliver solutions that restore quality of life for patients while maximizing the gift of tissue donation.
“With RTI Surgical’s singular focus on allograft and xenograft tissue-based implants, our team will provide expanded private label solutions for customers.
“Our expertise includes design, development, and processing in addition to all aspects of product life cycle management, regulatory compliance and Design History File ownership.”
Resolve Surgical Technologies, which will serve as a full-service partner, will engage in the designing, development, manufacturing and providing regulatory support for metal and polymer implants and instruments used in orthopaedics, spine and cardiothoracic applications.
The metals business current president Megan Osorio will act as CEO for Resolve Surgical Technologies, which was established in 1992 as Pioneer Surgical Technologies and was acquired by RTI Surgical in 2013.